aims: To describe the relationship between pancreas steatosis, hepatic steatosis and the coronary heart disease risk and effects in COVID-19 patients. background: Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis,pancreatic steatosis and coronary heart disease may increase risk of COVID-19 severity and prognosis. objective: To investigate the performance of a novel radiological-metabolic scoring (RM-S) system to predict mortality and intensive care unit (ICU) requirement among COVID-19 patients and to compare performance with the chest computed-tomography severity-scoring (C-CT-SS). method: Between May 2021 and January 2022, 397 patients with COVID-19 were included in this retrospective cohort study. All demographic, clinical and laboratory data, and chest CT images of patients were retrospectively reviewed. RM-S, V-CAC-S, HS-S, PS-S and C-CT-SS scores were calculated, and their performance to predict mortality and ICU requirement were evaluated by univariate and multivariable analyses. result: A total of 32 (8.1%) patients died and 77 (19.4%) patients required ICU admission. Mortality and ICU admission were both associated with older age (p < 0.001). Sex distribution was similar in the deceased vs. survivor and ICU vs. non-ICU comparisons (p = 0.974 and p = 0.626, respectively). Multiple logistic regression revealed that mortality was independently associated with having a C-CT-SS score of ≥14 (p < 0.001) and severe RM-S category (p = 0.010), while ICU requirement was independently associated with having a C-CT-SS score of ≥14 (p < 0.001) and severe V-CAC-S category (p = 0.010). conclusion: RM-S, C-CT-SS, and V-CAC-S are useful tools that can be used to predict patients with poor prognosis for COVID-19. Long-term prospective follow-up of patients with high RM-S scores can be useful for the prediction of long COVID.
Amaç: Semptomatik böbrek kistlerinin tedavisinde perkütan aspirasyon ve etanol skleroterapinin (PAS) güvenliğini, etkinliğini ve uzun dönem sonuçlarını değerlendirmek Gereç ve Yöntem: 2004 – 2020 yılları arasında tedavisinde perkütan aspirasyon ve etanol skleroterapi ile tedavi edilen 82 hasta, 90 kist retrospektif olarak değerlendirildi. Ortalama hasta yaşı 60.6 (28-86 arası) olup, 67 hasta yağ ağrısı (%81.8), 7 hasta hipertansiyon (%8.6), 3 hasta hidronefroz (%3.5) nedeniyle tedavi edildi. Ortalama takip süresi 59 aydı (1-220 ay). Girişimden sonra ardışık olarak 1, 3, 6, 12, 18. Ve 24. aylarda ve sonrasında yıllık olmak üzere takip edildi. Bulgular: Teknik başarı %100’dü. Prosedür ilişkili mortalite görülmedi. İşlem sonrası 3 (%3.9) hastada yan ağrısı, 1 hastada (% 1.3) hematüri gelişti. Hastaların 5’i ilk bir yıl içinde takipleri bıraktı. Birinci yıl sonunda ortalama kist hacminde azalma %93 olup kistlerin 19’u tamamen kayboldu. Bir yıllık takip sonunda radyolojik tam/tama yakın yanıt 77 hastanın 67’sinde (%78); parsiyel yanıt 13 hastada saptandı. Beş hastada tedaviye radyolojik yanıt yoktu. Sonuç: Semptomatik böbrek kistlerinin tedavisinde Ultrasonografi eşliğinde PAS, basit, iyi tolere edilen bir teknik olup düşük komplikasyon riski ve yüksek teknik başarı ile güvenle uygulanabilir.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.